Tag: Biotech and Pharma

The maker of healthcare products posted adjusted earnings of $1.21 per share for the third quarter, topping Wall Street’s call for $1.20, according to FactSet.

Johnson & Johnson raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and quarterly results that beat Wall Street expectations.

The World Health Organization said on Monday it had approved Bavarian Nordic’s mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the disease that has triggered global concern.

Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical group said on Friday.

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

Shares of German life sciences company Bayer fell nearly 7% on Wednesday, after a U.S. court said it would review a case alleging that exposure to products of the company’s Monsanto unit harmed individuals.

Activist investor Starboard Value has a roughly $1 billion stake in pharmaceutical giant Pfizer and is seeking to mount a turnaround at the struggling company, according to people familiar with the matter.

The Food and Drug Administration on Thursday approved Bristol Myers Squibb’s highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades.

Αύξηση των ενοποιημένων πωλήσεων παρουσιάζει ο Όμιλος Lavipharm κατά το α’ εξάμηνο του 2024. Συγκεκριμένα, οι ενοποιημένες πωλήσεις από συνεχιζόμενες δραστηριότητες ανήλθαν σε 30,6 εκατ. ευρώ έναντι 29,1 εκατ. ευρώ το αντίστοιχο διάστημα του 2023, σημειώνοντας αύξηση κατά 5,3%.

Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business.

Bavarian Nordic said on Thursday it could supply 13 million doses of its mpox vaccine by the end of 2025, up from a previous forecast of 10 million doses, and is exploring options to significantly expand its capacity.

Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines, in Ireland

The drug Liraglutide was shown in a Novo-sponsored late-stage clinical trial to have reduced the body-mass index (BMI) in children aged between 6-11.

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.

Merck  stock fell early Monday after a rival pharmaceutical company said its cancer drug beat Merck’s Keytruda in a head-to-head trial.

The World Health Organization earlier this month declared the Mpox outbreak a public-health emergency of international concern. (Dreamstime) were charging higher after the vaccine maker announced the Food and Drug Administration approved its smallpox vaccine for Mpox disease in individuals at high risk for infection.

GSK shares jumped Wednesday on news Delaware’s top court ruled in the pharmaceutical company’s favor, by agreeing to review the admissibility of expert evidence that could play a part in the British firm’s legal fight against claims its Zantac heartburn drug causes cancer.

Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for the popular injection, such as those with Medicare

Shares of Danish biotech company Bavarian Nordic jumped 13% on Thursday after it reported stronger-than-expected earnings and announced a bumper vaccine order from an unnamed European country amid the ongoing mpox outbreak.

Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday.